LIFECORE BIOMEDICAL INC DE
For the period ended May 26, 2024. Filed Aug 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Aug 26, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
As of May 26, 2024, the Company owned or leased the following principle physical properties:
| Location | Ownership | Facilities |
|---|---|---|
| Chaska, MN | Owned | 148,200 square feet of office, laboratory and manufacturing space |
| Chaska, MN | Leased | 80,950 square feet of office, manufacturing and warehouse space |
| Chanhassen, MN | Leased | 21,384 square feet of warehouse and office space |
Leases for these leased facilities expire at various dates through the year 2033. All of our owned real property is subject to liens in favor of the lenders under our 2020 credit agreement, as amended, with BMO Harris Bank N.A. (“BMO”) as administrative agent.
The Company does not anticipate experiencing significant difficulty in retaining occupancy of any of our manufacturing, laboratory, or office facilities through lease renewals prior to expiration or through month-to-month occupancy, or in replacing them with equivalent facilities. We believe our existing facilities, both owned and leased, are in good condition and suitable for the conduct of our business.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.